Sponsored by Ultragenyx Pharmaceutical Inc.
| Variant ID | 130 |
|---|---|
| Genomic Coordinate (GRCh38) | g.22076433_22076436dup |
| Variant | c.395_398dup |
| Variant Start Position | 395 |
| Location | Exon 4 |
| Amino Acid Change | p.Gln133Hisfs*14 |
| ACMG Call | - |
| ACMG Call Last Revised Date | 4/28/2021 |
| Predicted ACMG Call | Pathogenic | Effect Type | Frameshift |
| Variant Type | Small duplication |
| PMID | 24926462, 23079138, 21902834, 34806794 |
| Article Count | 4 |
| Times Observed | < 3 |
| Clinical Phenotype | nephrocalcinosis |
| ACMG Categories | pvs1, pm2, ppc |
| ACMG Explanations | pvs1: This is a loss of function variant. pm2: chrX:22094548 ref:C alt:CCATA was not found in gnomAD exomes or genomes. |
| Variant in Clinvar | No |
| ClinVar Classification | - |
| Categories In Literature | ppc |
| No Contrary Evidence Found | Yes |
| ExAC Allele Frequency | - |
| Thousand Genomes Allel Frequency | - |
| Ontology Relations | - |
| hg19 Mapping Failed | No |
| Literature Alleles | X-22094548-C-CCATA |
| GnomAD Alleles | - |
| DBNSFP Alleles | - |
| Other Alleles | - |
| Note | nan |
| Warnings | - |